I do wonder if their COViD trial will be held up by product supply issues. They have never had to supply so many cells in such a short time frame. And secondly, if the trial results are brilliant, and the US is happy to fork out 50k + per patient for the treatment, where are all the cells coming from? They couldn’t even keep up with the small demand in japan for GVHD. I would post the questions over their but I would be unlikely to receive a Substantiated reply.....
at least CYP could provide the cells, we just lack the salesman that MSB have
I do wonder if their COViD trial will be held up by product...
-
- There are more pages in this discussion • 319 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28229 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 12514 | 2 |
View Market Depth
| Last trade - 10.53am 26/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable